PE20040973A1 - Composiciones de anti-histaminicos, descongestivos y drogas anti-inflamatorias no esteroidales - Google Patents

Composiciones de anti-histaminicos, descongestivos y drogas anti-inflamatorias no esteroidales

Info

Publication number
PE20040973A1
PE20040973A1 PE2004000029A PE2004000029A PE20040973A1 PE 20040973 A1 PE20040973 A1 PE 20040973A1 PE 2004000029 A PE2004000029 A PE 2004000029A PE 2004000029 A PE2004000029 A PE 2004000029A PE 20040973 A1 PE20040973 A1 PE 20040973A1
Authority
PE
Peru
Prior art keywords
decongestive
nsaid
composition
dose
decongestives
Prior art date
Application number
PE2004000029A
Other languages
English (en)
Inventor
Roger Glen Berlin
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=32682029&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PE20040973(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of PE20040973A1 publication Critical patent/PE20040973A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Emergency Medicine (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Otolaryngology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

SE REFIERE A UNA COMPOSICION FARMACEUTICA QUE COMPRENDE UNA CANTIDAD EFECTIVA DE UNO DE LOS SIGUIENTES COMPUESTOS: (a) UNA DROGA ANTI-INFLAMATORIA NO ESTEROIDAL (NSAID) COMO IBUPROFENO, (b) UN DESCONGESTIVO COMO SEUDOEFEDRINA, Y (c) UN ANTI-HISTAMINICO ANTAGONISTA DEL RECEPTOR DE ANTIHISTAMINA H1 COMO CLORFENAMINA, Y OPCIONALMENTE (d) UN ANTITUSIVO, EN DONDE LA CANTIDAD EFECTIVA DEL DESCONGESTIVO O DEL ANTI-HISTAMINICO O AMBOS ES MENOR DEL 75% DE UNA CANTIDAD PRESENTE EN UNA DOSIS APROBADA, RELACIONADA CON UNA CANTIDAD DE NSAID CORRESPONDIENTE A 100% DE LA CANTIDAD PRESENTE EN UNA DOSIS APROBADA PARA ADULTO. ESTA COMPOSICION SE PUEDE PRESENTAR EN FORMA DE TABLETAS, TROQUEL, DISPERSION, SOLUCION, ELIXIR, CAPSULA O PARCHE. ESTA COMPOSICION ES UTIL PARA EL TRATAMIENTO DE LA RINITIS Y SINTOMAS SIMILARES AL RESFRIO, DEBIDO A QUE SE HA DEMOSTRADO QUE UN NSAID AUMENTA LA ACTIVIDAD DE UN DESCONGESTIVO Y UN ANTI-HISTAMINICO, PERMITIENDO ASI UNA REDUCCION DE CADA UNO O AMBOS EN LA ADMINISTRACION DE ESTAS EN FORMAS DE DOSIS SEPARADAS
PE2004000029A 2002-12-18 2004-01-05 Composiciones de anti-histaminicos, descongestivos y drogas anti-inflamatorias no esteroidales PE20040973A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US43434202P 2002-12-18 2002-12-18

Publications (1)

Publication Number Publication Date
PE20040973A1 true PE20040973A1 (es) 2004-12-14

Family

ID=32682029

Family Applications (2)

Application Number Title Priority Date Filing Date
PE2008000932A PE20081072A1 (es) 2002-12-18 2004-01-05 Composiciones de anti-histaminicos, descongestivos, antitusivos y drogas anti-inflamatorios no esteroidales
PE2004000029A PE20040973A1 (es) 2002-12-18 2004-01-05 Composiciones de anti-histaminicos, descongestivos y drogas anti-inflamatorias no esteroidales

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PE2008000932A PE20081072A1 (es) 2002-12-18 2004-01-05 Composiciones de anti-histaminicos, descongestivos, antitusivos y drogas anti-inflamatorios no esteroidales

Country Status (19)

Country Link
US (1) US7863287B2 (es)
EP (1) EP1572206B1 (es)
JP (1) JP2006515299A (es)
CN (2) CN1726035A (es)
AR (1) AR042543A1 (es)
AU (1) AU2003301188B2 (es)
CA (1) CA2508611C (es)
CL (1) CL2003002653A1 (es)
CO (1) CO5640087A2 (es)
ES (1) ES2468217T3 (es)
HK (2) HK1078494A1 (es)
MX (1) MXPA05006331A (es)
NZ (1) NZ540289A (es)
PE (2) PE20081072A1 (es)
PT (1) PT1572206E (es)
RU (1) RU2322262C2 (es)
TW (1) TWI313598B (es)
WO (1) WO2004056320A2 (es)
ZA (1) ZA200504908B (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1970055B1 (en) 2005-12-29 2010-11-24 Osmotica Kereskedelmi És Szolgáltató Kft Multi-layered tablet with triple release combination
WO2008114280A1 (en) * 2007-03-21 2008-09-25 Lupin Limited Novel reduced dose pharmaceutical compositions of fexofenadine and pseudoephedrine
TR201107202T1 (tr) * 2008-11-11 2012-02-21 Berko İlaç Ve Ki̇mya Sanayi̇ A.Ş. İbuprofen, psödoefedrin ve klorfeniramin içeren bir farmasötik bileşim.
CA2748728C (en) * 2009-01-05 2017-01-03 Mcneil-Ppc, Inc. Tablet containing cetirizine, pseudoephedrine, and naproxen containing a barrier layer
US8246988B2 (en) 2009-01-05 2012-08-21 Mcneil-Ppc, Inc. Three layer tablet containing cetirizine, pseudoephedrine, and naproxen
WO2010078541A1 (en) * 2009-01-05 2010-07-08 Mcneil-Ppc, Inc. Tablet containing coated particles of cetirizine, pseudoephedrine, and/or naproxen
PT2853262T (pt) * 2009-10-26 2017-01-31 Sephoris Pharmaceuticals Llc Tratamento de queimaduras solares usando analgésicos e anti-histamínicos
JP5777906B2 (ja) * 2010-02-26 2015-09-09 興和株式会社 ロキソプロフェン又はその塩含有の医薬組成物
WO2011137734A1 (en) * 2010-05-03 2011-11-10 Tsh Biopharm Company, Limited Pharmaceutical composition and method for treating hypertension
US8967989B2 (en) * 2010-07-19 2015-03-03 Procaps SAS Apparatus and process for encapsulating capsules or other solid dosage forms within capsules
JP5898963B2 (ja) * 2011-01-12 2016-04-06 興和株式会社 ロキソプロフェン又はその塩含有の医薬組成物
JP5898964B2 (ja) * 2011-01-12 2016-04-06 興和株式会社 ロキソプロフェン又はその塩を含有する医薬組成物
US9216181B2 (en) * 2011-06-08 2015-12-22 Southwest Research Institute BMP-2 upregulating compounds for healing bone tissue and screening methods for selecting such compounds
EP2968578B1 (en) * 2013-03-12 2019-06-26 Hercules LLC Coprocessed silica coated polymer composition
EP2965746B1 (en) 2014-07-10 2019-03-13 Santa Farma Ilaç Sanayi A.S. An oral pharmaceutical composition comprising ibuprofen, ibuprofen sodium dihydrate, pseudoephedrine hydrochloride and chlorpheniramine maleate
NZ735777A (en) 2015-03-26 2023-03-31 Jacqueline M Iversen Methods and compositions to inhibit symptoms associated with veisalgia
CN104758935B (zh) * 2015-04-10 2017-11-21 海口世康药物研究有限公司 一种改善复方布洛芬制剂稳定性的组合物及其制备方法
MX2019003039A (es) 2016-09-26 2019-07-08 Procter & Gamble Forma de dosificacion de alivio prolongado.

Family Cites Families (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4683243A (en) * 1984-02-08 1987-07-28 Richardson-Vicks, Inc. Analgesic and anti-inflammatory compositions comprising diphenhydramine and methods of using same
US4906625A (en) * 1984-02-08 1990-03-06 Richardson-Vicks, Inc. Analgesic and anti-inflammatory compositions comprising diphenhydramine and metyhods of using same
US4585783A (en) * 1984-02-08 1986-04-29 Richardson-Vicks, Inc. Analgesic and anti-inflammatory compositions comprising diphenhydramine and methods of using same
US4985459A (en) * 1984-02-08 1991-01-15 Richardson-Vicks, Inc. Analgesic and anti-inflammatory compositions comprising diphenhydramine and methods of using same
US4522826A (en) * 1984-02-08 1985-06-11 Richardson-Vicks Inc. Analgesic and anti-inflammatory compositions comprising diphenhydramine and methods of using same
US4755532A (en) * 1984-02-08 1988-07-05 Richardson-Vicks, Inc. Analgesic and anti-inflammatory compositions comprising diphenhydramine and methods of using same
US5025019A (en) * 1984-04-09 1991-06-18 Analgesic Associates Cough/cold mixtures comprising non-steroidal anti-inflammatory drugs
US4552899A (en) 1984-04-09 1985-11-12 Analgesic Associates Cough/cold mixtures comprising non-steroidal anti-inflammatory drugs
AU738274B2 (en) 1984-04-09 2001-09-13 Procter & Gamble Company, The Cough/cold mixtures comprising non-steroidal anti-inflammatory drugs
US4783465A (en) * 1984-04-09 1988-11-08 Analgesic Associates Cough/cold mixtures comprising non-sedating antihistamine drugs
US4840962A (en) * 1984-04-09 1989-06-20 Analgesic Associates Cough/cold mixtures comprising non-steroidal anti-inflammatory drugs
US4871733A (en) * 1984-04-09 1989-10-03 Analgesic Associates Cough/cold mixtures comprising non-sedating antihistamine drugs
IE58110B1 (en) * 1984-10-30 1993-07-14 Elan Corp Plc Controlled release powder and process for its preparation
US4829064A (en) * 1987-06-08 1989-05-09 Analgesic Associates Cough/cold mixtures comprising non-sedating antihistamine drugs
US4975426A (en) * 1987-06-08 1990-12-04 Analgesic Associates Cough/cold mixtures comprising non-sedating antihistamine drugs
US4971785A (en) * 1988-03-14 1990-11-20 Spectrum Consumer Products Co., Inc. Non-alcoholic delivery system for orally ingestible active ingredients
US5288479A (en) * 1989-01-17 1994-02-22 Sterling Drug, Inc. Extrudable elastic oral pharmaceutical gel compositions and metered dose dispensers containing them and method of making and method of use thereof
US4990535A (en) * 1989-05-03 1991-02-05 Schering Corporation Pharmaceutical composition comprising loratadine, ibuprofen and pseudoephedrine
US5133974A (en) * 1989-05-05 1992-07-28 Kv Pharmaceutical Company Extended release pharmaceutical formulations
NZ234143A (en) * 1989-06-28 1991-10-25 Mcneil Ppc Inc Aqueous pharmaceutical suspension formulation for administering substantially insoluble pharmaceutical agents
AU8505991A (en) 1990-09-11 1992-03-30 Richardson-Vicks Inc. Use of compositions containing 2-(6'-substituted-2'-naphthyl)-acetic acid derivatives for the treatment of respiratory disorders
AU662297B2 (en) 1990-09-11 1995-08-31 Richardson-Vicks Inc. Method for providing improved analgesic effect
US5196436A (en) * 1990-10-31 1993-03-23 The Procter & Gamble Company Dextromethorphan antitussive compositions
JPH06506684A (ja) 1991-04-01 1994-07-28 メルク　エンド　カンパニー　インコーポレーテッド イブプロフェン−充血除去剤配合物
US5492689A (en) * 1991-11-19 1996-02-20 The Center For Innovative Technology Combined virustatic antimediator (COVAM) treatment of common colds
CA2084028A1 (en) 1991-11-27 1993-05-28 Harish B. Pandya Hot flu composition
US5968551A (en) * 1991-12-24 1999-10-19 Purdue Pharma L.P. Orally administrable opioid formulations having extended duration of effect
US6303632B1 (en) * 1992-09-03 2001-10-16 Sepracor Inc. Compositions for treating allergic and other disorders using norastemizole in combination with other active ingredients
JPH08506808A (ja) * 1992-12-21 1996-07-23 ザ、プロクター、エンド、ギャンブル、カンパニー 呼吸障害治療用組成物の製造における鎮痛剤ｓ（＋）対掌体の利用
BR9307697A (pt) * 1992-12-21 1999-05-25 Procter & Gamble Composições contendo cafeína e s(+)-ibuprofeno ou s(+)-flubiprofeno ou s(+)-quetoprofeno
DE69431153T2 (de) * 1993-06-04 2003-03-13 Warner Lambert Co Zubereitungen enthaltend siliciumdioxid zur verbesserung ihres geschmacks
US5466865A (en) * 1993-07-02 1995-11-14 Ibah, Inc. Neomorphic ibuprofen and methods of using same
WO1995007103A1 (en) 1993-09-07 1995-03-16 The Procter & Gamble Company Compositions containing an amino acid salt of propionic acid non-steroidal anti-inflammatory agent and at least one of a decongestant, an expectorant, an antihistamine and an antitussive
WO1995007079A1 (en) 1993-09-07 1995-03-16 The Procter & Gamble Company Compositions containing an amino acid salt of propionic acid non-steroidal anti-inflammatory agents and caffeine
KR100338877B1 (ko) 1993-10-25 2002-12-05 메렐 파마슈티칼스 인크. 테르페나딘과이부프로펜의안정한약제학적조성물
US5560913A (en) * 1995-01-27 1996-10-01 The Procter & Gamble Company Pharmaceutical compositions
US5622723A (en) * 1995-02-03 1997-04-22 Eurand America, Incorporated Procedure for encapsulating chlorpheniramine
WO1997004808A1 (en) 1995-07-28 1997-02-13 The Procter & Gamble Company Compositions containing analgesics and antihistamines and methods for treating respiratory disorders
US5766622A (en) 1996-08-14 1998-06-16 The Procter & Gamble Company Inhibiting undesirable taste in oral compositions
US6210710B1 (en) * 1997-04-28 2001-04-03 Hercules Incorporated Sustained release polymer blend for pharmaceutical applications
US5895663A (en) * 1997-07-31 1999-04-20 L. Perrigo Company Pseudoephedrine hydrochloride extended-release tablets
US5869479A (en) * 1997-08-14 1999-02-09 Schering Corporation Treatment of upper airway allergic responses
AU8744398A (en) 1997-09-19 1999-04-12 Procter & Gamble Company, The Compositions and methods for treating respiratory disorders
US6337091B1 (en) * 1997-10-27 2002-01-08 Temple University - Of The Commonwealth System Of Higher Education Matrix for controlled delivery of highly soluble pharmaceutical agents
WO1999021556A1 (en) * 1997-10-29 1999-05-06 J-Med Pharmaceuticals, Inc. Antihistamine/decongestant regimens for treating rhinitis
US6090411A (en) * 1998-03-09 2000-07-18 Temple University Monolithic tablet for controlled drug release
US6267986B1 (en) 1999-09-24 2001-07-31 Ranbaxy Laboratories Limited Process for the preparation of a controlled drug delivery system containing pseudoephedrine and a long acting antihistamine
AU2276801A (en) * 1999-12-20 2001-07-03 Schering Corporation Extended release oral dosage composition
WO2003024427A1 (en) * 1999-12-20 2003-03-27 Temple University Of The Commonwealth System Of Higher Education Tableted oral extended release dosage form
JP2002316927A (ja) 2001-04-19 2002-10-31 Taisho Pharmaceut Co Ltd 感冒用組成物
US20040147606A1 (en) 2001-05-25 2004-07-29 Yoichi Onuki Medicinal compositions
AU2003219348A1 (en) 2002-04-22 2003-11-03 Adcock Ingram Intellectual Property (Proprietary) Limited Pharmaceutical compositions comprising a decongenstant and further active ingredients for treating cough and flu
AU2003302447A1 (en) 2002-11-22 2004-06-18 Kumamoto Technology And Industry Foundation Moving body navigate information display method and moving body navigate information display device
WO2005063219A2 (en) 2003-12-23 2005-07-14 Ranbaxy Laboratories Limited Ibuprofen-containing soft gelatin capsules

Also Published As

Publication number Publication date
US20040186184A1 (en) 2004-09-23
ES2468217T3 (es) 2014-06-16
AR042543A1 (es) 2005-06-22
CN102406642B (zh) 2013-04-03
EP1572206B1 (en) 2014-04-23
MXPA05006331A (es) 2005-08-26
AU2003301188A1 (en) 2004-07-14
WO2004056320A2 (en) 2004-07-08
PT1572206E (pt) 2014-06-12
CO5640087A2 (es) 2006-05-31
EP1572206A2 (en) 2005-09-14
CN102406642A (zh) 2012-04-11
US7863287B2 (en) 2011-01-04
TWI313598B (en) 2009-08-21
TW200413004A (en) 2004-08-01
RU2005122403A (ru) 2006-01-20
NZ540289A (en) 2006-10-27
EP1572206A4 (en) 2007-07-18
RU2322262C2 (ru) 2008-04-20
JP2006515299A (ja) 2006-05-25
AU2003301188B2 (en) 2009-07-02
CL2003002653A1 (es) 2005-04-22
CA2508611C (en) 2011-07-26
HK1166602A1 (en) 2012-11-02
WO2004056320A3 (en) 2004-09-23
CA2508611A1 (en) 2004-07-08
CN1726035A (zh) 2006-01-25
ZA200504908B (en) 2006-12-27
HK1078494A1 (en) 2006-03-17
PE20081072A1 (es) 2008-08-15

Similar Documents

Publication Publication Date Title
PE20040973A1 (es) Composiciones de anti-histaminicos, descongestivos y drogas anti-inflamatorias no esteroidales
HRP20200600T1 (hr) Tapentadol za sprječavanje i liječenje depresije i tjeskobe
ES2916649T1 (es) Composiciones y usos para el tratamiento de la esclerosis múltiple
ECSP055569A (es) Forma de dosificación de pramipexol en una dosis única diaria
AR066420A1 (es) Composicion farmaceutica suministrable oronasofaringeamente para la prevencion alivio / y o tratamiento de trastornos de miembros inquietos. uso.
BRPI0508342A (pt) formulações farmacêuticas
ECSP10010224A (es) Formulaciones líquidas de hormona luteinizante (lh).
JP2009541443A5 (es)
AR084816A1 (es) Metodos y medicamentos para el tratamiento de la enfermedad de alzheimer
AR070026A1 (es) Conjunto de elementos para la dosificacion de 1-amino-alquilciclohexanos, tal como neramexano, y tratamiento de diversas enfermedades incluyendo el tinnitus
AR075735A1 (es) Composiciones farmaceuticas de liberacion inmediata que comprenden oxicodona y naloxona. uso
AR077284A1 (es) Composiciones de dosis fija farmaceuticas solidas que comprenden irbesartan y amlodipina, su preparacion y su aplicacion terapeutica
AR062167A1 (es) Sistema de administracion gastrorretentivo
ES2914120T3 (es) Procedimientos de uso de derivados de amida cíclicos para tratar trastornos mediados por el receptor sigma
AR046036A1 (es) Composiciones de risedronato y metodos para su uso
ECSP099348A (es) Composición farmacéutica de liberación modificada de un músculo relajante y un aine
AR105184A1 (es) Comprimidos de liberación inmediata que contienen un fármaco y procesos para formar los comprimidos
JP2008100924A (ja) 総合感冒薬組み合わせ製剤
AR066666A1 (es) Composicion farmaceutica que comprende la combinacion de un agente antiinflamatorio no esteroideo y un agente anticonvulsivante
BRPI0510855A (pt) medicamento em forma de pelìcula para ministração oral e uso de estriol e/ou de ésteres de estriol farmaceuticamente aceitáveis
HRP20231177T1 (hr) Kombinacija tvari za uporabu u regenerativnoj terapiji kod pacijenata sa šećernom bolesti tipa 1
PE20040670A1 (es) Nuevas composiciones farmaceuticas que contienen ambroxol y yoduro de isopropamida
AR047684A1 (es) Composiciones de drogas descongestivas o anti-histaminicas y anti-inflamatorios no esteroides
AR067465A1 (es) Composicion farmaceutica que comprende la combinacion de un agente derivado benzisoxazolico y un agente benzodiazepinico
CL2008003584A1 (es) Uso de la 10-[(3r)-1-azabiciclo]oct-3-ilmetil]-10-h-fenotiazina, o una de sus sales farmaceuticamente aceptables para la preparación de un medicamento util para prevenir o tratar la bronconeumopatia obstructiva.

Legal Events

Date Code Title Description
FC Refusal